Literature DB >> 1599390

Binding of human plasminogen to basement-membrane (type IV) collagen.

M S Stack1, T L Moser, S V Pizzo.   

Abstract

Plasminogen, the zymogen form of the serine proteinase plasmin, has been implicated in numerous physiological and pathological processes involving extracellular-matrix remodelling. We have previously demonstrated that the activation of plasminogen catalysed by tissue plasminogen activator is dramatically stimulated in the presence of basement-membrane-specific type IV collagen [Stack, Gonzalez-Gronow & Pizzo (1990) Biochemistry 29, 4966-4970]. The present paper describes the binding of plasminogen to type IV collagen. Plasminogen binds to both the alpha 1(IV) and alpha 2(IV) chains of basement-membrane collagen, with binding to the alpha 2(IV) chain preferentially inhibited by 6-aminohexanoic acid. This binding is specific and saturable, with Kd,app. values of 11.5 and 12.7 nM for collagen and gelatin respectively. Although collagen also binds to immobilized plasminogen, this interaction is unaffected by 6-aminohexanoic acid. Limited elastase proteolysis of plasminogen generated distinct collagen-binding fragments, which were identified as the kringle 1-3 and kringle 4 domains. No binding of collagen to mini-plasminogen was observed. These studies demonstrate a specific interaction between plasminogen and type IV collagen and provide further evidence for regulation of plasminogen activation by protein components of the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599390      PMCID: PMC1132703          DOI: 10.1042/bj2840103

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Thrombospondin interaction with plasminogen. Evidence for binding to a specific region of the kringle structure of plasminogen.

Authors:  P DePoli; T Bacon-Baguley; S Kendra-Franczak; M T Cederholm; D A Walz
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

2.  Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.

Authors:  Y Okada; T Morodomi; J J Enghild; K Suzuki; A Yasui; I Nakanishi; G Salvesen; H Nagase
Journal:  Eur J Biochem       Date:  1990-12-27

3.  A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization.

Authors:  Y Okada; H Nagase; E D Harris
Journal:  J Biol Chem       Date:  1986-10-25       Impact factor: 5.157

4.  Evidence for the involvement of type II domains in collagen binding by 72 kDa type IV procollagenase.

Authors:  L Bányai; L Patthy
Journal:  FEBS Lett       Date:  1991-04-22       Impact factor: 4.124

5.  Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen.

Authors:  G Murphy; C G McAlpine; C T Poll; J J Reynolds
Journal:  Biochim Biophys Acta       Date:  1985-09-20

6.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

7.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

Authors:  I E Collier; S M Wilhelm; A Z Eisen; B L Marmer; G A Grant; J L Seltzer; A Kronberger; C S He; E A Bauer; G I Goldberg
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

8.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

9.  In vitro biosynthesis of plasminogen in a cell-free system directed by mRNA fractions isolated from monkey liver.

Authors:  M Gonzalez-Gronow; K C Robbins
Journal:  Biochemistry       Date:  1984-01-17       Impact factor: 3.162

10.  Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.

Authors:  R Reich; E W Thompson; Y Iwamoto; G R Martin; J R Deason; G C Fuller; R Miskin
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

View more
  9 in total

1.  Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.

Authors:  M S Stack; S Gately; L M Bafetti; J J Enghild; G A Soff
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 2.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

3.  Plasminogen activators in ischemic stroke: introduction.

Authors:  Gregory J del Zoppo
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

4.  Specific conformational changes of plasminogen induced by chloride ions, 6-aminohexanoic acid and benzamidine, but not the overall openness of plasminogen regulate, production of biologically active angiostatins.

Authors:  Debra J Warejcka; Sally S Twining
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

5.  Collagen type IV stimulates an increase in intracellular Ca2+ in pancreatic acinar cells via activation of phospholipase C.

Authors:  L Somogyi; Z Lasić; S Vukicević; H Banfić
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

6.  Lp(a)/apo(a) modulate MMP-9 activation and neutrophil cytokines in vivo in inflammation to regulate leukocyte recruitment.

Authors:  Menggui Huang; Yanqing Gong; Jessica Grondolsky; Jane Hoover-Plow
Journal:  Am J Pathol       Date:  2014-03-17       Impact factor: 4.307

7.  Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.

Authors:  T L Moser; J J Enghild; S V Pizzo; M S Stack
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

8.  Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins.

Authors:  M Ranson; N M Andronicos; M J O'Mullane; M S Baker
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

Review 9.  Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination.

Authors:  Sarbani Bhattacharya; Victoria A Ploplis; Francis J Castellino
Journal:  J Biomed Biotechnol       Date:  2012-10-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.